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Down Syndrome (DS) is caused by the trisomy of human chromosome 21 (Hsa21).  
Trisomy 21 can cause various behavioral, cognitive, learning and memory deficits. 
Deficits in hippocampal structure and function have been identified in mouse 
models of DS and are implicated in cognitive and learning impairments. Mouse 
models have suggested that deficits in cognitive function are associated with 
overexpression of Dyrk1a, a gene on Hsa21 found in three copies of individuals with 
DS.  Dyrk1a is a gene that is involved in brain development and function. Ts65Dn DS 
model mice exhibit trisomy for approximately half of the genes on Hsa21 including 
Dyrk1a and exhibit cognitive and learning impairments. We are using Ts65Dn mice 
to test the effects of Epigallocatechin gallate (EGCG), a Dyrk1a inhibitor, on Dyrk1a 
activity and cognitive function. We hypothesize that EGCG will reduce Dyrk1a 
activity in the hippocampus and improve hippocampal-dependent spatial learning 
and memory in the Morris water maze place learning task in Ts65Dn mice. The mice 
were given daily EGCG treatment (200 mg/kg per day) by means of oral gavage 
beginning on postnatal day 54 and continuing throughout water maze testing 
(postnatal days 67-74).  Measures of spatial learning included latency and path 
length to find a submerged platform during acquisition trials (postnatal days 67-73). 
Memory for the previously learned location of the platform was assessed on a probe 
trial (postnatal day 74) in which the platform was removed and the amount of time 
spent swimming in the area of the tank previously containing the platform was 
measured. These measures allowed us to analyze the mice’s ability to learn and 
remember the position of the platform and to spatially orient themselves. 
Preliminary data indicates that EGCG treatment may not be an effective treatment 
for the spatial learning and memory deficits evident in this mouse model of DS.  
